Sana Biotechnology, Inc. operates as a biotechnology company. The Company focuses on creating and delivering engineered cells as medicine for patients. Sana Biotechnology replaces damaged cells and tissues and treats broad array of diseases.

Quarterly Report (Form 10-Q | Period ending 2024-09-30)

Current Report (Form 8-K | Period ending 2024-11-08)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Sana Biotechnology Inc (SANA US)

Quarterly Report (Form 10-Q | Period ending 2024-09-30)

Current Report (Form 8-K | Period ending 2024-11-08)

Current Report (Form 8-K | Period ending 2024-10-04)

Current Report (Form 8-K | Period ending 2024-09-06)

Current Report (Form 8-K | Period ending 2024-08-08)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)